Related Experiment Video
Updated: Mar 28, 2026

05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
1.1K
[REVIEW OF CLINICAL STUDIES ON COMBINATION THERAPY OF 5α-REDUCTASE INHIBITORS AND α1-BLOCKERS IN PATIENTS WITH BENIGN
Urologiia (Moscow, Russia : 1999)
|December 16, 2015
Summary
Combination therapy using 5α-reductase inhibitors and α-blockers significantly improves quality of life for benign prostatic hyperplasia (BPH) patients. This approach offers better safety, prevents BPH progression, and reduces the need for surgery compared to monotherapy.
Area of Science:
- Urology
- Pharmacology

